Italy Pharmaceutical and Medical Goods Expenditure Share (2025)
Italy's Pharmaceutical and Medical Goods Expenditure Share: 20.8 % of current health expenditure in 2025, +0.1pp YoY. Eurostat (HLTH_SHA11_HC), 2016–2025.
Italy (2025)
20.8
% of current health expenditure
+0.1pp YoY
YoY Change
+0.1pp
percentage points
Trend
up
Series length
10
years of data
Data
| Year | % of current health expenditure | YoY Change |
|---|---|---|
| 2025 | 20.8 | +0.1pp |
| 2024 | 20.7 | +0.3pp |
| 2023 | 20.4 | +0.2pp |
| 2022 | 20.2 | +0.4pp |
| 2021 | 19.8 | -0.6pp |
| 2020 | 20.4 | -0.7pp |
| 2019 | 21.1 | +0.5pp |
| 2018 | 20.6 | +0.4pp |
| 2017 | 20.2 | -0.2pp |
| 2016 | 20.4 | n/a |
About this Dataset
Italy recorded 20.8 % of current health expenditure in 2025. The latest change was +0.1pp. Across 2016–2025 the series ranges from 19.8 in 2021 to 21.1 in 2019.
This page tracks the share of current health expenditure devoted to pharmaceuticals and medical goods in Italy.
Data sourced from Eurostat via SDMX REST API. Values use harmonised methodology intended for cross-country comparison.
Frequently Asked Questions
This page tracks the share of current health expenditure devoted to pharmaceuticals and medical goods in Italy. It is published by Eurostat and updated annually.
The most recent observation covers 2025. Eurostat typically publishes this series with a lag of several months after the reference period. The series runs 2016–2025 (10 observations).
The series peaked at 21.1 % of current health expenditure in 2019 and reached its lowest recorded value of 19.8 in 2021. The latest reading of 20.8 in 2025 represents a change of +0.1pp.